Abeona Therapeutics
Working together to find a cure
238 employees · est. 2015 · Cleveland, United States
Spur Therapeutics
Toward the next generation of gene therapy.
122 employees · est. 2015 · Stevenage, United Kingdom
Abeona Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Abeona Therapeutics | Spur Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2015 | 2015 |
| Headquarters | ||
| Headquarters | Cleveland, United States | Stevenage, United Kingdom |
| Employees | ||
| Employees | 238 larger | 122 |
| Industry | ||
| Industry | Biotechnology, Health Care, Manufacturing | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | IPO | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $289.85M | $260.50M |
| Funding Rounds | ||
| Funding Rounds | 9 | 7 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Abeona Therapeutics, Gene Therapy, Cell Therapy, Genetic Medicine, Rare Diseases, Lysosomal Storage Diseases, Infantile Batten Disease, Sanfilippo Syndrome, Epidermolysis Bullosa, Cystic Fibrosis, Retinal Diseases, Manufacturing Facility, AIM Vector Platform, AAV Capsids | Gene Therapy, Liver-directed, Inherited Diseases, Clinical Trials, AAV-based Therapy, Hemophilia B, Fabry Disease, Gaucher Disease, Haemophilia A, Innovation, Global Locations, Systemic Diseases, United Kingdom, United States |
| Website | ||
| Website | abeonatherapeutics.com | spurtherapeutics.com |
About Abeona Therapeutics
Abeona Therapeutics is a pioneering gene and cell therapy company, listed on Nasdaq under the ticker ABEO. The company operates across manufacturing, delivery, development, and discovery of gene and cell therapies, positioning itself uniquely for success in the rapidly advancing field of genetic med...
About Spur Therapeutics
Freeline is a biopharmaceutical company focused on developing liver-directed gene therapies for inherited systemic diseases. With clinical programs for Hemophilia B and Fabry disease, and preclinical programs in Gaucher disease and haemophilia A, the company aims to revolutionize treatment options f...
We will tell you when either one moves
BounceWatch watches Abeona Therapeutics and Spur Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Abeona Therapeutics and Spur Therapeutics — by email.
Frequently Asked Questions
Compare Abeona Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Abeona Therapeutics on 9 Jun 2026, and Spur Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.